CYTK says MYQORZO launch gains momentum with 40% new-to-brand

CYTK said MYQORZO is seeing strong momentum, including over 40% new-to-brand share, with goals to exceed 50% by year-end; it cited physician education, improved market access, and rapid reimbursement, plus European expansion and upcoming regulatory milestones for pipeline programs.